Volume 9, Issue 2 (May 2022)                   Avicenna J Neuro Psycho Physiology 2022, 9(2): 45-50 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bakhshayesh Eghbali B, Pourramzani A, Bahadivand Chegini A H, Mirniam L, Hasanzadeh K, Saadat S. Validity and Reliability of Connor-Davidson Resilience Scale in Patients with Multiple Sclerosis: A Psychometric Study in Iran. Avicenna J Neuro Psycho Physiology. 2022; 9 (2) :45-50
URL: http://ajnpp.umsha.ac.ir/article-1-404-en.html
1- Associate Professor of Neurology, Neuroscience Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
2- Assistant Professor, Department of Psychiatry, Kavosh Behavioural, Cognitive and Addiction Sciences Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
3- MA of General Psychology, Prisoners Organization and Security and Educational Measures, Education and Research Center, Gilan, Iran.
4- MA in Counseling, Department of Counseling, Faculty of Education and Psychology, Alzahra University, Tehran, Iran.
5- Neuroscience Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran.
6- PhD in Psychology, Neuroscience Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran. , sajjadsaadat69@gmail.com
Abstract:   (203 Views)

Background and Objective: Resilience refers to a protective factor that reduces stress in people with multiple sclerosis (PwMS). Given the significance of this issue, the present research aimed to assess the validity and reliability of the Connor-Davidson Resilience Scale (CD-RISC) in PwMS.
Materials and Methods: The present cross-sectional study aimed to assess the psychometric properties of CD-RISC in the statistical population of Guilan MS Society (GMSS). In this study, 442 people with MS participated and responded to CD-RISC in an online survey. The data were analyzed in SPSS (version 23) and Amos (version 21) software packages.
Results: The confirmatory factor analysis results of the first stage with five factors revealed that 25 CD-RISC items benefited from high factor load and good fit indices were reported (ꭕ2=605.55; df=265; P-Value=.0001; ꭕ2/df=2.28; GFI=.88; CFI=.93; TLI=.92; RMR=.06; RMSEA=.05); therefore, CD-RISC has good construct validity. Cronbach’s alpha coefficients for the whole scale and subscales were calculated at 0.94 and 0.71-0.89, respectively, indicating the optimal reliability of CD-RISC in PwMS.
Conclusions: The current study presented evidence for CD-RISC validity and reliability. Further studies are recommended to ensure the psychometric properties of this scale in other chronic patients.

Full-Text [PDF 1510 kb]   (67 Downloads) |   |   Full-Text (HTML)  (10 Views)  
Article Type: Research Article | Subject: General
Received: 2021/10/12 | Accepted: 2022/01/31 | Published: 2022/05/9

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY 4.0 | Avicenna Journal of Neuro Psycho Physiology

Designed & Developed by : Yektaweb